Search
for
Sort by
Research 31–60 of 297
- Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis
- Severe dermographism after topical therapy with diphenylcyclopropenone for alopecia universalis
- Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions
- Treatment of Alopecia Areata With Topical Sensitizers
- Clinical efficacy of diphenylcyclopropenone in alopecia areata: Retrospective data analysis of 50 patients
- Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers
- Effects of diphencyprone on expression of Bcl-2 protein in patients with Alopecia areata
- Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata
- Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata
- Alopecia areata – Current understanding and management
- Update on the Treatment of Alopecia Areata
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin
- Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens
- Phototherapy as a Useful Therapeutic Option in the Treatment of Diphenylcyclopropenone-induced Vitiligo
- Efficacy of topical diphenylcyclopropenone maintenance treatment for patients with alopecia areata: A retrospective study
- Allergic contact dermatitis from dyes in wigs following diphencyprone treatment
- Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp: a prospective, split‐face comparative study
- Osteopontin: a new facilitating factor in alopecia areata pathogenesis?
- Distinguishing Lipedematous Scalp, Lipedematous Alopecia, and Diffuse Alopecia Areata
- Extensive Scalp Angioedema following High-Dose Diphenylcyclopropenone for Alopecia Areata
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Use of diphenylcyclopropenone for alopecia areata treatment during pregnancy
- Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis
- Economic Impact of Home-Use versus Office-Use Diphenylcyclopropenone in Extensive Alopecia Areata
- Comparative Study between The Efficacy and Safety of Topical Immune Therapy with Diphenylcyclopropenone versus Anthralin in The Treatment of Resistant Alopecia Areata
- Topical Immunotherapy with Diphenylcyclopropenone in Paediatric Patients with Alopecia Areata—A Retrospective Study of 97 Patients
- Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata
- Alopecia universalis. Partial response to tofacitinib
- Pharmacological Treatment of Alopecia